Hofseth Biocare ASA
OSE:HBC

Watchlist Manager
Hofseth Biocare ASA Logo
Hofseth Biocare ASA
OSE:HBC
Watchlist
Price: 1.38 NOK -3.5% Market Closed
Market Cap: 545.2m NOK
Have any thoughts about
Hofseth Biocare ASA?
Write Note

Hofseth Biocare ASA
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hofseth Biocare ASA
Cash & Cash Equivalents Peer Comparison

Comparables:
B
BGBIO
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Hofseth Biocare ASA
OSE:HBC
Cash & Cash Equivalents
kr25.3m
CAGR 3-Years
-39%
CAGR 5-Years
5%
CAGR 10-Years
20%
B
Bergenbio ASA
OSE:BGBIO
Cash & Cash Equivalents
kr200.1m
CAGR 3-Years
-30%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Cash & Cash Equivalents
kr27.4m
CAGR 3-Years
-1%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Cash & Cash Equivalents
kr170.3m
CAGR 3-Years
-1%
CAGR 5-Years
51%
CAGR 10-Years
7%
N
Nykode Therapeutics ASA
OSE:NYKD
Cash & Cash Equivalents
$136.5m
CAGR 3-Years
-8%
CAGR 5-Years
29%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Cash & Cash Equivalents
kr29.6m
CAGR 3-Years
-60%
CAGR 5-Years
-42%
CAGR 10-Years
-5%

See Also

What is Hofseth Biocare ASA's Cash & Cash Equivalents?
Cash & Cash Equivalents
25.3m NOK

Based on the financial report for Jun 30, 2024, Hofseth Biocare ASA's Cash & Cash Equivalents amounts to 25.3m NOK.

What is Hofseth Biocare ASA's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
20%

Over the last year, the Cash & Cash Equivalents growth was 51%. The average annual Cash & Cash Equivalents growth rates for Hofseth Biocare ASA have been -39% over the past three years , 5% over the past five years , and 20% over the past ten years .

Back to Top